Press Release Details

Quest Diagnostics Appoints Harris Koffer to Lead Clinical Trials Division

04/24/2000

TETERBORO, N.J., April 24, 2000 —

Dr. Koffer joins Quest Diagnostics from Covance, Inc., where he had served as Corporate Vice President and General Manager of Clinical Trials Research and Development. Previously, he was Corporate Vice President and General Manager of Covance Clinical Services, responsible for Covance’s full service clinical research and development capabilities for Phases 2 and 3 of drug development in North America.

“We are excited about the knowledge and more than 20 years of experience that Harris Koffer brings to our clinical trials business,” said Vijay Aggarwal, Ph.D., President of Quest Diagnostics Ventures.

Dr. Koffer earned a B.S. degree in Pharmacy and a Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Science, and completed a fellowship in Clinical Pharmacology at Thomas Jefferson University Hospital.

Quest Diagnostics is the nation's leading provider of diagnostic testing, information and services with annualized revenues of more than $3 billion. The testing performed on human specimens helps doctors diagnose, treat and monitor disease; enables employers to detect workplace drug abuse; and supports pharmaceutical and biotechnology companies in clinical trials of new therapeutics worldwide. Quest Informatics analyzes laboratory and other medical data to help healthcare providers improve the care of patients. Additional company information can be found on the Internet at: www.questdiagnostics.com.

# # #